missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18557209

CD82/Kai-1 Antibody (423524), Janelia Fluor™ 549, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB4616I

Product Code. 18557209

  • € 691.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD82/Kai-1 Monoclonal antibody specifically detects CD82/Kai-1 in Human samples. It is validated for Flow Cytometry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD82/Kai-1
Monoclonal
Janelia Fluor 549
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry, CyTOF
423524
Flow Cytometry, CyTOF-ready
CD82 antigenC33, CD82 molecule, IA4C33 antigen, Inducible membrane protein R2, KAI1GR15, kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyteantigen, antigen detected by monoclonal and IA4)), Metastasis suppressor Kangai-1, R2, SAR2tetraspanin-27, ST6tspan-27, Suppressor of tumorigenicity 6 protein, Tetraspanin-27, Tspan-27, TSPAN274F9
NS0 mouse myeloma cell line transfected with human CD82/Kai-1, Met1-Tyr267, Accession # AAH01821
0.1 mL
Cancer
3732
Store at 4°C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.